# Tag: pharmaceutical regulation

- [Anvisa Reviews Elevidys, a R$20 Million Gene Therapy Suspended in Brazil](https://brazilstockguide.com/insights/anvisa-reviews-elevidys-r20-million-gene-therapy-brazil/) (2026-04-29): Brazil’s health regulator is waiting for additional safety and efficacy data from Roche before deciding whether the treatment can return to the market.
- [When State Failure Becomes a Public Health Risk](https://brazilstockguide.com/opinion/nelson-mussolini/when-state-failure-becomes-a-public-health-risk/) (2026-03-31): Regulatory gaps in Brazil’s drug market highlight growing risks in safety, compliance, and institutional credibility.
- [Brazil’s Anvisa Expands Medical Cannabis Rules, Allows Compounding Pharmacies](https://brazilstockguide.com/insights/brazil-anvisa-medical-cannabis-regulation/) (2026-01-28): Regulatory overhaul broadens administration routes, eases access to THC therapies and marks a milestone for patient treatment.
